The one-step BCA / HB combined test is based on a unique combination of monoclonal and polyclonal antibodies to selectively detect with a high degree of sensitivity. The targeted bladder tumor marker is the human factor H protein, a known marker for bladder cancer. The test sensitivity is between 56% – 91% depending on the stage and grade of the bladder tumor.
Exposure time: 9 minutes.
Designed for professional in vitro diagnostic use only.
Sensitivity: 97.1% vs. biopsy (G3 clinical sensitivity, BCA, HB)
Specificity: 72% compared to biopsy (group of patients previously diagnosed with bladder cancer)
It quickly provides a diagnosis of common cancers, such as bladder, colon and prostate.
These rapid tests simultaneously detect the antigen of urinary cancer (hcFHrp) and hemoglobin.
Packaging Mode:
- 10 individual packaging boxes;
- Individually packaged pipettes,
- 10 urine harvesters,
- 10 urine harvester covers,
Price displayed / kit
CE marking, no. Lot, Germany production
It is sold to the 10 test kit.
Recenzii
Nu există recenzii până acum.